Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib plus nivolumab plus /- ipilimumab

被引：0
|
作者：
Iannantuono, Giovanni Maria
Chandran, Elias
Simon, Nicholas I.
Ley, Lisa
Cordes, Lisa M.
Wang, Tzu-fang
Girardi, Daniel da Motta
Gurram, Sandeep
Valera, Vladimir
Chalfin, Heather
Parnes, Howard L.
Nadal, Rosa
Niglio, Scot Anthony
Boudjadi, Salah
Banday, Abdul Rouf
Kydd, Andre Rashad
Steinberg, Seth M.
Apolo, Andrea B.
机构：
[1] NCI, Genitourinary Malignancies Branch, CCR, NIH, Bethesda, MD USA
[2] Hosp Sirio Libanes, Brasilia, MD, Brazil
[3] NCI, Urol Oncol Branch, CCR, NIH, Bethesda, MD USA
[4] Frederick Hlth Hosp, Frederick, MD USA
[5] NCI, Div Canc Prevent, CCR, NIH, Bethesda, MD USA
[6] NHLBI, Cellular & Mol Therapeut Branch, Lab Transplantat Immunotherapy, NIH, Bethesda, MD USA
[7] NYU, Grossman Sch Med, New York, NY USA
[8] NCI, Biostat & Data Management Sect, OCD, NIH, Bethesda, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16506
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Pemphigus vulgaris as an immune-related adverse event in recurrent metastatic esophageal squamous cell carcinoma treated with ipilimumab plus nivolumab: a case report and literature review
    Nakamura, Hajime
    Shionoya, Aika
    Arihara, Yohei
    Hayasaka, Naotaka
    Kubo, Tomohiro
    Usami, Makoto
    Sugita, Shintaro
    Uhara, Hisashi
    Takada, Kohichi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experience
    J Gao
    Q He
    S Subudhi
    A Aparicio
    A Zurita-Saavedra
    D H Lee
    C Jimenez
    M Suarez-Almazor
    P Sharma
    Oncogene, 2015, 34 : 5411 - 5417
  • [33] Review of immune-related adverse events in prostate cancer patients treated with ipilimumab: MD Anderson experience
    Gao, J.
    He, Q.
    Subudhi, S.
    Aparicio, A.
    Zurita-Saavedra, A.
    Lee, D. H.
    Jimenez, C.
    Suarez-Almazor, M.
    Sharma, P.
    ONCOGENE, 2015, 34 (43) : 5411 - 5417
  • [34] Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab
    Ishihara, Hiroki
    Takagi, Toshio
    Kondo, Tsunenori
    Homma, Chie
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Kobayashi, Hirohito
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (06) : 355.e21 - 355.e29
  • [35] Immune-Related Adverse Events of Genitourinary Cancer Patients, a Retrospective Cohort Study
    Hunting, John C.
    Deyo, Logan
    Olson, Eric
    Faucheux, Andrew T.
    Price, Sarah N.
    Lycan Jr, Thomas W.
    CANCERS, 2024, 16 (17)
  • [36] Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab
    Tirumani, Sree Harsha
    Ramaiya, Nikhil H.
    Keraliya, Abhishek
    Bailey, Nancy D.
    Ott, Patrick A.
    Hodi, F. Stephen
    Nishino, Mizuki
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10) : 1185 - 1192
  • [37] Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab plus Ipilimumab
    Friedman, Claire F.
    Clark, Varina
    Raikhel, Andrew V.
    Barz, Tim
    Shoushtari, Alexander N.
    Momtaz, Parisa
    Callahan, Margaret K.
    Wolchok, Jedd D.
    Chapman, Paul B.
    Hellmann, Matthew D.
    Postow, Michael A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (04):
  • [38] Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab
    Yoshiyasu Kono
    Yasuhiro Choda
    Masahiro Nakagawa
    Koji Miyahara
    Michihiro Ishida
    Tetsushi Kubota
    Keiji Seo
    Tetsu Hirata
    Yuka Obayashi
    Tatsuhiro Gotoda
    Yuki Moritou
    Yoshiko Okikawa
    Yasuo Iwamoto
    Hiroyuki Okada
    Targeted Oncology, 2021, 16 : 237 - 248
  • [39] Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.
    Masuda, Ken
    Shoji, Hirokazu
    Nagashima, Kengo
    Yamamoto, Shun
    Ishikawa, Masashi
    Imazeki, Hiroshi
    Aoki, Masahiko
    Miyamoto, Takahiro
    Hirano, Hidekazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab
    Kono, Yoshiyasu
    Choda, Yasuhiro
    Nakagawa, Masahiro
    Miyahara, Koji
    Ishida, Michihiro
    Kubota, Tetsushi
    Seo, Keiji
    Hirata, Tetsu
    Obayashi, Yuka
    Gotoda, Tatsuhiro
    Moritou, Yuki
    Okikawa, Yoshiko
    Iwamoto, Yasuo
    Okada, Hiroyuki
    TARGETED ONCOLOGY, 2021, 16 (02) : 237 - 248
12345